Search research articles
Contact Us
Filters
Showing results (531-540 of 647) with videos related to
Page
of 65
Sort By:
Cell
|
August 15, 2017
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
Spencer C Wei, Jacob H Levine, Alexandria P Cogdill, et al.
Annals of the New York Academy of Sciences
|
June 19, 2013
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
Jedd D Wolchok, F Stephen Hodi, Jeffrey S Weber, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 23, 2019
Combination anti-CTLA-4 plus anti-PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies
Spencer C Wei, Nana-Ama A S Anang, Roshan Sharma, et al.
Cancer Immunology, Immunotherapy : CII
|
April 6, 2011
CTLA-4 blockade increases antigen-specific CD8(+) T cells in prevaccinated patients with melanoma: three cases
Jianda Yuan, Brian Ginsberg, David Page, et al.
Science (New York, N.Y.)
|
March 9, 2013
Aire-dependent thymic development of tumor-associated regulatory T cells
Sven Malchow, Daniel S Leventhal, Saki Nishi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2009
The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research
Martin A Cheever, James P Allison, Andrea S Ferris, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 25, 2010
Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas
Xingxing Zang, Peggy S Sullivan, Robert A Soslow, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 6, 2004
Augmentation of T cell levels and responses induced by androgen deprivation
Anja C Roden, Michael T Moser, Samuel D Tri, et al.
Cancer Immunology Research
|
August 31, 2019
Blockade of CTLA-4 and PD-1 Enhances Adoptive T-cell Therapy Efficacy in an ICOS-Mediated Manner
Lewis Zhichang Shi, Sangeeta Goswami, Tihui Fu, et al.
Nature Medicine
|
August 4, 2015
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
Sara Lovisa, Valerie S LeBleu, Björn Tampe, et al.
Page
of 65
Search research articles
Search
Showing results (531-540 of 647) with videos related to
Sort By:
Page
of 65
Cell
|
August 15, 2017
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
Spencer C Wei, Jacob H Levine, Alexandria P Cogdill, et al.
Annals of the New York Academy of Sciences
|
June 19, 2013
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
Jedd D Wolchok, F Stephen Hodi, Jeffrey S Weber, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 23, 2019
Combination anti-CTLA-4 plus anti-PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies
Spencer C Wei, Nana-Ama A S Anang, Roshan Sharma, et al.
Cancer Immunology, Immunotherapy : CII
|
April 6, 2011
CTLA-4 blockade increases antigen-specific CD8(+) T cells in prevaccinated patients with melanoma: three cases
Jianda Yuan, Brian Ginsberg, David Page, et al.
Science (New York, N.Y.)
|
March 9, 2013
Aire-dependent thymic development of tumor-associated regulatory T cells
Sven Malchow, Daniel S Leventhal, Saki Nishi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2009
The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research
Martin A Cheever, James P Allison, Andrea S Ferris, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 25, 2010
Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas
Xingxing Zang, Peggy S Sullivan, Robert A Soslow, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 6, 2004
Augmentation of T cell levels and responses induced by androgen deprivation
Anja C Roden, Michael T Moser, Samuel D Tri, et al.
Cancer Immunology Research
|
August 31, 2019
Blockade of CTLA-4 and PD-1 Enhances Adoptive T-cell Therapy Efficacy in an ICOS-Mediated Manner
Lewis Zhichang Shi, Sangeeta Goswami, Tihui Fu, et al.
Nature Medicine
|
August 4, 2015
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
Sara Lovisa, Valerie S LeBleu, Björn Tampe, et al.
Page
of 65